/Companies

310 AI

Founded 2022 · 8 employees on LinkedIn · 3 known investors

Find your way into 310 AI

Sign up to see every warm intro you have to 310 AI

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the 310 AI team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

310.ai is building an AI operating system for life sciences, applying generative AI to biology for applications such as computational protein design. The company serves researchers and biotechs working in drug discovery and therapeutic development.

Founders & leadership

310 AI was founded in 2022 by Kooshiar Azimian.

KAKooshiar Azimian
Kooshiar AzimianFounder & CEO
KA
Koosh AzimianFounder
KYKathy Y. Wei, Ph.D.
Kathy Y. Wei, Ph.D.CSO & FounderA protein engineer working on machine learning approaches to molecular design, she previously served as a scientist and senior scientist at Amgen and held postdoctoral appointments in Daniel Fletcher's lab at UC Berkeley and David Baker's lab at the University of Washington. She earned her Ph.D. in Christina Smolke's lab at Stanford University and is currently incubating a stealth venture.

Investors · 3

Frequently asked questions

What does 310 AI do?
310.ai is building an AI operating system for life sciences, applying generative AI to biology for applications such as computational protein design. The company serves researchers and biotechs working in drug discovery and therapeutic development.
Who founded 310 AI?
310 AI was founded by Kooshiar Azimian in 2022.
Who are 310 AI's investors?
310 AI's investors include Capria Ventures, Cota Capital, The E14 Fund.